Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-23,800
Closed -$2.07M 1791
2020
Q4
$2.07M Buy
23,800
+7,400
+45% +$640K 0.02% 698
2020
Q3
$1.47M Hold
16,400
0.02% 683
2020
Q2
$1.71K Sell
16,400
-69,700
-81% -$6.72M 0.02% 614
2020
Q1
$6.3M Buy
86,100
+71,000
+470% +$5.36M 0.07% 245
2019
Q4
$1.32M Buy
15,100
+3,700
+32% +$316K 0.01% 1298
2019
Q3
$846K Buy
11,400
+11,300
+11,300% +$913K 0.01% 1600
2019
Q2
$8K Sell
100
-19,900
-100% -$1.6M ﹤0.01% 2450
2019
Q1
$1.72M Buy
+20,000
New +$1.63M 0.01% 991
2018
Q3
Sell
-10,000
Closed -$670K 2562
2018
Q2
$670K Buy
+10,000
New +$684K ﹤0.01% 1452
2014
Q4
Sell
-10,000
Closed -$491K 2134
2014
Q3
$491K Buy
+10,000
New +$501K ﹤0.01% 1344
2013
Q4
Sell
-50,000
Closed -$1.91M 2057
2013
Q3
$1.91M Buy
+50,000
New +$1.48M 0.02% 624

Other funds holding INCY

Jefferies Group's INCY Position: Q3 2022 in Review

Jefferies Group opened a new position in Incyte (INCY) in Q3 2022: 100,000 shares worth $6.66M. The stake represents 0.06% of the portfolio and ranks #282 among its holdings. This is a return to the name: Jefferies Group previously reported a position in INCY as recently as Q1 2022.

Jefferies Group first reported a position in INCY in Q3 2013 and has held it in 32 quarters since. The position peaked at $7.31M in Q2 2021. 536 funds tracked by Wall St. Rank hold INCY as of Q3 2022.

  • Jefferies Group held 100,000 shares of Incyte worth $6.66M as of Q3 2022.
  • Incyte was a new Jefferies Group position in Q3 2022.
  • Incyte made up 0.06% of Jefferies Group's portfolio in Q3 2022, its #282 holding.
  • Jefferies Group first reported a position in Incyte in Q3 2013 and has held it in 32 quarters since.
  • Jefferies Group's Incyte position peaked at $7.31M in Q2 2021.
  • 536 funds tracked by Wall St. Rank held Incyte as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.